Literature DB >> 11257056

Blocking the receptor for interleukin 10 protects mice from lethal listeriosis.

R A Silva1, R Appelberg.   

Abstract

High doses of Listeria monocytogenes overcome the ability of a normal mouse to control the infection, due to massive bacterial replication. Treatment with an anti-interleukin 10 (IL-10) receptor monoclonal antibody prevented the fatal course of infection with high doses of bacteria. This work shows that blocking the receptor for IL-10 may have useful therapeutic applications.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11257056      PMCID： PMC90465          DOI： 10.1128/AAC.45.4.1312-1314.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

Review 1.  Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response.

Authors:  E R Unanue
Journal:  Immunol Rev       Date:  1997-08       Impact factor: 12.988

2.  Role of IL-10 in a neonatal mouse listeriosis model.

Authors:  F Genovese; G Mancuso; M Cuzzola; C Biondo; C Beninati; D Delfino; G Teti
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

3.  Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice.

Authors:  W J Dai; G Köhler; F Brombacher
Journal:  J Immunol       Date:  1997-03-01       Impact factor: 5.422

4.  In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.

Authors:  R T Gazzinelli; M Wysocka; S Hieny; T Scharton-Kersten; A Cheever; R Kühn; W Müller; G Trinchieri; A Sher
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

5.  Increased antimycobacterial immunity in interleukin-10-deficient mice.

Authors:  P J Murray; R A Young
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

6.  Increased resistance to mycobacterial infection in the absence of interleukin-10.

Authors:  M Jacobs; N Brown; N Allie; R Gulert; B Ryffel
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

7.  Role of macrophages and alpha beta T lymphocytes in early interleukin 10 production during Listeria monocytogenes infection.

Authors:  I E Flesch; S H Kaufmann
Journal:  Int Immunol       Date:  1994-03       Impact factor: 4.823

8.  Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice.

Authors:  R D Wagner; N M Maroushek; J F Brown; C J Czuprynski
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  Evaluation of IL-12 in immunotherapy and vaccine design in experimental Mycobacterium avium infections.

Authors:  R A Silva; T F Pais; R Appelberg
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

10.  A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice.

Authors:  C Li; I Corraliza; J Langhorne
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441
View more
  12 in total

1.  Mice Lacking Fatty Acid-Binding Protein 5 Are Resistant to Listeria monocytogenes.

Authors:  Deviyani M Rao; Della T Phan; Michelle J Choo; Amie L Owen; Anne-Laure Perraud; Fabienne Gally
Journal:  J Innate Immun       Date:  2019-03-18       Impact factor: 7.349

2.  The β2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion.

Authors:  Didem Ağaç; Leonardo D Estrada; Robert Maples; Lora V Hooper; J David Farrar
Journal:  Brain Behav Immun       Date:  2018-09-05       Impact factor: 7.217

3.  A deficiency in gamma interferon or interleukin-10 modulates T-Cell-dependent responses to heat shock protein 60 from Histoplasma capsulatum.

Authors:  Mark Scheckelhoff; George S Deepe
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

4.  A filarial parasite-encoded human IL-10 receptor antagonist reveals a novel strategy to modulate host responses.

Authors:  Alessandra Ricciardi; Sergio A Hassan; Olena Kamenyeva; Sasisekhar Bennuru; John Andersen; Thomas B Nutman
Journal:  PNAS Nexus       Date:  2022-09-07

5.  Role of interleukin-4 (IL-4) and IL-10 in serum immunoglobulin G antibody responses following mucosal or systemic reovirus infection.

Authors:  Alicia R Mathers; Christopher F Cuff
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

6.  Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung.

Authors:  Paul S Redford; Andre Boonstra; Simon Read; Jonathan Pitt; Christine Graham; Evangelos Stavropoulos; Gregory J Bancroft; Anne O'Garra
Journal:  Eur J Immunol       Date:  2010-08       Impact factor: 5.532

7.  Inhibition of IL-10 production by maternal antibodies against Group B Streptococcus GAPDH confers immunity to offspring by favoring neutrophil recruitment.

Authors:  Pedro Madureira; Elva Bonifácio Andrade; Bernardo Gama; Liliana Oliveira; Susana Moreira; Adília Ribeiro; Margarida Correia-Neves; Patrick Trieu-Cuot; Manuel Vilanova; Paula Ferreira
Journal:  PLoS Pathog       Date:  2011-11-17       Impact factor: 6.823

8.  Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection.

Authors:  Julio Aliberti; Charles Serhan; Alan Sher
Journal:  J Exp Med       Date:  2002-11-04       Impact factor: 14.307

9.  Hyperbilirubinemia in Gunn Rats is Associated with Decreased Inflammatory Response in LPS-Mediated Systemic Inflammation.

Authors:  Petra Valaskova; Ales Dvorak; Martin Lenicek; Katerina Zizalova; Nikolina Kutinova-Canova; Jaroslav Zelenka; Monika Cahova; Libor Vitek; Lucie Muchova
Journal:  Int J Mol Sci       Date:  2019-05-09       Impact factor: 5.923

10.  TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production.

Authors:  Finlay W McNab; John Ewbank; Ricardo Rajsbaum; Evangelos Stavropoulos; Anna Martirosyan; Paul S Redford; Xuemei Wu; Christine M Graham; Margarida Saraiva; Philip Tsichlis; Damien Chaussabel; Steven C Ley; Anne O'Garra
Journal:  J Immunol       Date:  2013-07-10       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.